Despite tactful handling of its Fidelis lead recall, Medtronic (MDT - Cramer’s Take - Stockpickr - Rating) may have more problems on the horizon with the insulated defibrillation wires, according to a Deutsche Bank research report late last week.
Despite tactful handling of its Fidelis lead recall, Medtronic (MDT - Cramer’s Take - Stockpickr - Rating) may have more problems on the horizon with the insulated defibrillation wires, according to a Deutsche Bank research report late last week.
